Publications by authors named "Carballo David"

Claim this Profile
E
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes.
Maëlle Achard, Cédric Follonier, Evelyne Fournier, David Carballo, Mattia Branca, David Nanchen

Eur J Clin Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evolving journey of cardiac rehabilitation.
David Carballo

Eur Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention.
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, Joris Holtrop, Lisa Pennells, David Carballo

Eur Heart J Qual Care Clin Outcomes· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of the Healthy Diet Characteristics Recommended by the 2021 ESC Guidelines with Vascular Events in Patients with Established CVD.
L L F Hoes, J M Geleijnse, F Mach, Y M Smulders, David Carballo

Eur J Prev Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis.
Noverraz Viviane, Carballo Sebastian, Carballo David, Meyer Philippe, Garin Nicolas

Int J Cardiol Heart Vasc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.
Nicolas Johner, Mattia Branca, David Carballo, Stéphanie Baggio, David Nanchen

Eur J Prev Cardiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the intensity of statin therapy and physical activity 1 year after acute coronary syndrome: a multicentre prospective cohort study in Switzerland.
Alex Boudon, Isabella Locatelli, Baris Gencer, David Carballo, Roland Klingenberg, David Nanchen

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cardiology. Heart failure, cardiac imaging, congenital heart diseases, and cardio-oncology].
Christina Gkotsoulia, Virginie Tacchini, Adelin Barrier, Damien Guijarro, Dionysios Adamopoulos, David Carballo

Rev Med Suisse· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes.
Cédric Follonier, Gabriel Rabassa, Mattia Branca, David Carballo, Konstantinos Koskinas, David Nanchen

Atheroscler Plus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome.
Kristina Krasieva, Baris Gencer, Isabella Locatelli, David Carballo, Olivier Muller, David Nanchen

Circ Cardiovasc Qual Outcomes· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome.
Elena Tessitore, Mattia Branca, Dik Heg, David Nanchen, Reto Auer, David Carballo

Eur J Prev Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2021 European Society for Cardiology prevention guideline's stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease.
Joris Holtrop, Deepak L Bhatt, Kausik K Ray, François Mach, Yvo M Smulders, David Carballo

Eur J Prev Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: desmoplakin cardiomyopathy presenting as an inflammatory cardiomyopathy with repeated sudden cardiac arrests.
Emmanuelle Massie, Arnaud Dominati, Sebastian Suchet, David Carballo, Elsa Hervier

Eur Heart J Case Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acetazolamide in acute heart failure].
Mickaël Jolti, Pauline Darbellay Farhoumand, David Carballo, Sebastian Carballo

Rev Med Suisse· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium).
Konstantinos C Koskinas, Raphael Twerenbold, David Carballo, Christian M Matter, Stephane Cook

Front Cardiovasc Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesoamerican urbanism revisited: Environmental change, adaptation, resilience, persistence, and collapse.
Diane Z Chase, José Lobo, Gary M Feinman, David M Carballo, Arlen F Chase

Proc Natl Acad Sci U S A· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction.
Barbara E Stähli, Roland Klingenberg, Dik Heg, Mattia Branca, Robert Manka, David Carballo

J Am Coll Cardiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
Cédric Follonier, Elena Tessitore, Sandra Handgraaf, David Carballo, Maëlle Achard

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation and depression after acute coronary syndrome.
Kristina Krasieva, Carole Clair, Baris Gencer, David Carballo, Roland Klingenberg, David Nanchen

Prev Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks and benefits of urinary catheterisation during inpatient diuretic therapy for acute heart failure: a retrospective, non-inferiority, cohort study.
Gregor John, Marc Arcens, Gregory Berra, Nicolas Garin, David Carballo

BMJ Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study.
Lauriane Gilgien-Dénéréaz, Julian Jakob, Kali Tal, Baris Gencer, David Carballo, David Nanchen

Swiss Med Wkly· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice].
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Davide Capodanno

G Ital Cardiol (Rome)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
Roland Klingenberg, Barbara E Stähli, Dik Heg, Andrea Denegri, Robert Manka, David Carballo

Am Heart J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC).
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Davide Capodanno

Rev Esp Cardiol (Engl Ed)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[European guidelines 2021 for the cardiovascular prevention: new concepts].
Evgenia Vasilakou, David Carballo, David Nanchen

Rev Med Suisse· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis